T1	intervention 36 46	famotidine
T2	total-participants 391 401	Forty-five
T3	eligibility 402 439	patients with operable breast cancers
T4	intervention-participants 441 443	25
T5	control-participants 491 493	20
T6	control 494 502	controls
T7	outcome 594 610	Significant TILs
T8	iv-bin-percent 624 627	75%
T9	iv-bin-abs 629 631	18
T10	intervention-participants 632 634	24
T11	cv-bin-percent 659 662	35%
T12	cv-bin-abs 664 665	7
T13	control-participants 666 668	20
T14	outcome 976 991	disease relapse
T15	outcome 1339 1360	disease free survival
T16	outcome 1527 1548	disease free survival
